Park JH - Search Results

1

Identification of neoantigen-specific T cells and their targets: implications for immunotherapy of head and neck squamous cell carcinoma.

Ren L, Leisegang M, Deng B, Matsuda T, Kiyotani K, Kato T, Harada M, Park JH, Saloura V, Seiwert T, Vokes E, Agrawal N, Nakamura Y. Ren L, et al. Among authors: park jh. Oncoimmunology. 2019 Feb 6;8(4):e1568813. doi: 10.1080/2162402X.2019.1568813. eCollection 2019. Oncoimmunology. 2019. PMID: 30906664 Free PMC article.

2

PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer.

Park JH, Lin ML, Nishidate T, Nakamura Y, Katagiri T. Park JH, et al. Cancer Res. 2006 Sep 15;66(18):9186-95. doi: 10.1158/0008-5472.CAN-06-1601. Cancer Res. 2006. PMID: 16982762

3

Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family.

Lin ML, Park JH, Nishidate T, Nakamura Y, Katagiri T. Lin ML, et al. Among authors: park jh. Breast Cancer Res. 2007;9(1):R17. doi: 10.1186/bcr1650. Breast Cancer Res. 2007. PMID: 17280616 Free PMC article.

4

Critical roles of T-LAK cell-originated protein kinase in cytokinesis.

Park JH, Nishidate T, Nakamura Y, Katagiri T. Park JH, et al. Cancer Sci. 2010 Feb;101(2):403-11. doi: 10.1111/j.1349-7006.2009.01400.x. Epub 2009 Oct 12. Cancer Sci. 2010. PMID: 19900192 Free PMC article.

5

Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin.

Park JH, Katagiri T, Chung S, Kijima K, Nakamura Y. Park JH, et al. Neoplasia. 2011 Apr;13(4):320-6. doi: 10.1593/neo.101440. Neoplasia. 2011. PMID: 21472136 Free PMC article.

6

TOPK inhibitor induces complete tumor regression in xenograft models of human cancer through inhibition of cytokinesis.

Matsuo Y, Park JH, Miyamoto T, Yamamoto S, Hisada S, Alachkar H, Nakamura Y. Matsuo Y, et al. Among authors: park jh. Sci Transl Med. 2014 Oct 22;6(259):259ra145. doi: 10.1126/scitranslmed.3010277. Sci Transl Med. 2014. PMID: 25338756

7

Characterization of T cell repertoire of blood, tumor, and ascites in ovarian cancer patients using next generation sequencing.

Jang M, Yew PY, Hasegawa K, Ikeda Y, Fujiwara K, Fleming GF, Nakamura Y, Park JH. Jang M, et al. Among authors: park jh. Oncoimmunology. 2015 Apr 14;4(11):e1030561. doi: 10.1080/2162402X.2015.1030561. eCollection 2015 Nov. Oncoimmunology. 2015. PMID: 26451311 Free PMC article.

8

Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer.

Inoue H, Kato T, Olugbile S, Tamura K, Chung S, Miyamoto T, Matsuo Y, Salgia R, Nakamura Y, Park JH. Inoue H, et al. Among authors: park jh. Oncotarget. 2016 Mar 22;7(12):13621-33. doi: 10.18632/oncotarget.7297. Oncotarget. 2016. PMID: 26871945 Free PMC article.

9

Oncogenic roles of TOPK and MELK, and effective growth suppression by small molecular inhibitors in kidney cancer cells.

Kato T, Inoue H, Imoto S, Tamada Y, Miyamoto T, Matsuo Y, Nakamura Y, Park JH. Kato T, et al. Among authors: park jh. Oncotarget. 2016 Apr 5;7(14):17652-64. doi: 10.18632/oncotarget.7755. Oncotarget. 2016. PMID: 26933922 Free PMC article.

10

Morphological Changes, Cadherin Switching, and Growth Suppression in Pancreatic Cancer by GALNT6 Knockdown.

Tarhan YE, Kato T, Jang M, Haga Y, Ueda K, Nakamura Y, Park JH. Tarhan YE, et al. Among authors: park jh. Neoplasia. 2016 May;18(5):265-272. doi: 10.1016/j.neo.2016.03.005. Epub 2016 Apr 15. Neoplasia. 2016. PMID: 27237318 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,439 results

Search Page

Filters